The CMS on Thursday proposed significantly reducing reimbursement for medications purchased by hospitals under the 340B discount program, designed for facilities that care for poor populations. The proposal would reduce rates to 22.5% below the average sales price for a given drug, down from the average sales price plus 6%. The CMS also is seeking comments on whether Medicare should pay for knee replacements as well as partial and total hip procedures performed in outpatient settings, a change that could affect bundled payments for such procedures.
CMS proposes steep cuts to 340B drug reimbursement rates
Sign up for AHIP Solutions SmartBrief
Health care industry news for insurers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.